Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study
Top Cited Papers
Open Access
- 24 June 2020
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 12 (12), 11245-11258
- https://doi.org/10.18632/aging.103372
Abstract
Background: The World Health Organization has declared coronavirus disease 2019 (COVID-19) a public health emergency of global concern. Updated analysis of cases might help identify the risk factors of illness severity. Results: The median age was 63 years, and 44.9% were severe cases. Severe patients had higher APACHE II (8.5 vs. 4.0) and SOFA (2 vs. 1) scores on admission. Among all univariable parameters, lymphocytes, CRP, and LDH were significantly independent risk factors of COVID-19 severity. LDH was positively related both with APACHE II and SOFA scores, as well as P/F ratio and CT scores. LDH (AUC = 0.878) also had a maximum specificity (96.9%), with the cutoff value of 344.5. In addition, LDH was positively correlated with CRP, AST, BNP and cTnI, while negatively correlated with lymphocytes and its subsets. Conclusions: This study showed that LDH could be identified as a powerful predictive factor for early recognition of lung injury and severe COVID-19 cases. Methods: We extracted data regarding 107 patients with confirmed COVID-19 from Renmin Hospital of Wuhan University. The degree of severity of COVID-19 patients (severe vs. non-severe) was defined at the time of admission according to American Thoracic Society guidelines for community acquired pneumonia.Keywords
All Related Versions
This publication has 29 references indexed in Scilit:
- Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironmentsCancer Biomarkers, 2017
- Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanismScience, 2016
- Use of LDH and Autoimmune Side Effects to Predict Response to Ipilimumab TreatmentImmunotherapy, 2016
- 2009 pandemic Influenza A (H1N1): clinical and laboratory characteristics in pediatric and adult patients and in patients with pulmonary involvementInfluenza and Other Respiratory Viruses, 2012
- HIV-Associated Pneumocystis PneumoniaProceedings of the American Thoracic Society, 2011
- Pneumocystisinfection in humans: diagnosis and treatmentExpert Review of Anti-infective Therapy, 2010
- LDH Concentration in Nasal-Wash Fluid as a Biochemical Predictor of Bronchiolitis SeverityPediatrics, 2010
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Significant Changes of Peripheral T Lymphocyte Subsets in Patients with Severe Acute Respiratory SyndromeThe Journal of Infectious Diseases, 2004
- Lactate dehydrogenase (LDH) isoenzymes and proliferative activity of lymphoid cells—an immunocytochemical studyClinical and Experimental Immunology, 1991